Criticare Division
Think Critical Care. Think Gufic.
Pioneers of lyophilized formulations in India, reaching 5,000+ hospitals with high-quality critical care therapies backed by global regulatory standards.
WHO WE ARE
Leaders in Critical Care
Backed by strong R&D and fully automated, zero-human-touch lyophilization facilities, Gufic Critical Care has built a portfolio of 130+ globally registered products across 15+ countries, touching millions of lives.
With expertise in anti-infectives, antifungals, and complex injectables, our solutions are trusted by over 25,000 healthcare professionals across India. Supported by approvals from EU-GMP, MHRA (UK), Health Canada, TGA (Australia), WHO-GMP India, and 40+ global regulatory bodies, our manufacturing and quality systems meet stringent international standards for critical.
Facts & Figures
Reach and Impact
Healthcare Professionals Reached
Hospitals Pan India
Global Regulatory Approvals
OUR PORTFOLIO
An Extensive Therapeutic Basket
Antibacterials
Doxycycline Inj., Ceftazidime + Avibactam, Polymyxin, Tigecycline
Antifungals
Caspofungin, Micafungin, Anidulafungin, Isavuconazole, Liposomal Amphotericin B
Immunomodulators
Thymosin Alpha-1 (Immunocin Alpha)
WHAT SETS US APART
Patient-Centric Differentiators
Science-backed formulations with clinically proven advantages, each designed to raise the bar in critical care treatment.
Immunocin Alpha
- First and only Indian company to conduct Phase 3 trial in COVID patients
- First and only Indian company to conduct Phase 3 trial in sepsis with DCGI approval
Doxific
- Only brand with inbuilt ascorbic acid advantage preventing doxycycline oxidation
- 50% fewer impurities than conventional brands
Dalbavan
- Only company to conduct Phase 3 trial with 256 patients in the Indian population
- First Indian company to receive DCGI approval
- In-house manufactured API complying to global standards
Guficap
- First Indian company to launch affordable Caspofungin at global quality standards
- Only Indian company to develop a brand stable at 25°C
Micafung Plus
- Only Indian brand with lactose-free process patent technology for better stability
Canidula
- Indigenously manufactured through process patent technology
Isavufic
- First Indian company to launch Isavuconazole injection and affordable oral capsule at global quality standards
OUR TEAMS
Dedicated Teams, Focused Impact
Specialized teams built around distinct care settings, ensuring targeted reach across every tier of the Indian healthcare ecosystem.
Explore Our Products
Innovation-Driven Solutions
Pioneering research and development to enhance treatment options.
Stronger Healthcare Ecosystem
Supporting hospitals and professionals with advanced therapeutics.
Global Reach, Local Impact
Delivering high-quality solutions that make a difference worldwide.
News & Articles
Stay Informed with Our Latest Highlights
Discover the latest achievements, partnerships, and innovations shaping our journey.